Key result
Early DAPT de-escalation linked to ~6.7-fold higher risk of delayed ischemic stroke vs late switch.
Cohort (n=395)
Answers are grounded in this paper and cite their sources.
PURPOSE: To evaluate characteristics of delayed ischemic stroke after stent-assisted coil placement in cerebral aneurysms and to determine the optimal duration of dual antiplatelet therapy for its prevention. MATERIALS AND METHODS: This retrospective study was approved by the institutional review board, and the requirement to obtain written informed consent was waived. Of 1579 patients with 1661 aneurysms, 395 patients (25.0%) with 403 aneurysms (24.3%) treated with stent-assisted coil placement were included and assigned to groups stratified as early (126 patients [31.9%]; 3 months of coil placement), midterm (160 patients [40.5%]; 6 months), or late (109 patients [27.6%]; ≥ 9 months), according to the time points of switching dual antiplatelet therapy to monotherapy from coil placement. Cumulative rates of delayed ischemic stroke in each group were calculated by using Kaplan-Meier estimates that were compared with log-rank tests. Risk factors of delayed ischemic stroke were identified by using Cox proportional hazard analysis. RESULTS: Delayed ischemic stroke occurred in 3.5% of all cases (embolism, 3.0%; thrombotic occlusion, 0.5%) within 2 months following the switch. Late switch yielded no delayed ischemic stroke, unlike early (seven of 126 patients [5.6%]; P = .013) or midterm (seven of 160 patients [4.4%]; P = .028) switch. Incomplete occlusion (hazard ratio, 6.68 [95% confidence interval: 1.490, 29.900]) was identified as a risk factor. CONCLUSION: Delayed ischemic stroke after stent-assisted coil placement is caused by embolism from or thrombotic occlusion of stent-containing vessels after switching from dual antiplatelet therapy to monotherapy. The stent-containing vessel with incomplete aneurysm occlusion presents as a long-term thromboembolic source. Therefore, dual antiplatelet therapy for more than 9 months and late switch to monotherapy are recommended for its prevention.
No takes yet. Share an insight, caveat, or question.
Hwang et al. (2014) conducted a cohort in Cerebral aneurysm treated with stent-assisted coil placement (n=395). Late switch (≥9 months) from dual antiplatelet therapy to monotherapy vs. Early (3 months) or midterm (6 months) switch to monotherapy was evaluated on Delayed ischemic stroke (HR 6.68, 95% CI 1.490-29.900, p=0.013). Late switch (≥9 months) from dual antiplatelet therapy to monotherapy yielded 0% delayed ischemic stroke vs 5.6% for early (P=0.013) and 4.4% for midterm switch (P=0.028).
Synapse has enriched 10 related papers. Consider them for comparative context: